Compare PYPD & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPD | FSI |
|---|---|---|
| Founded | 2008 | 1991 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7M | 63.7M |
| IPO Year | 2014 | 2000 |
| Metric | PYPD | FSI |
|---|---|---|
| Price | $4.62 | $5.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.25 | N/A |
| AVG Volume (30 Days) | ★ 282.9K | 23.0K |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,494,325.00 |
| Revenue This Year | N/A | $63.39 |
| Revenue Next Year | N/A | $43.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.06 | $4.86 |
| 52 Week High | $5.73 | $11.48 |
| Indicator | PYPD | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 33.01 |
| Support Level | $4.18 | $4.90 |
| Resistance Level | $5.07 | $5.19 |
| Average True Range (ATR) | 0.27 | 0.13 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 84.33 | 43.28 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.